Royalty Pharma Asset Turnover Growth & History (RPRX)

Royalty Pharma's asset turnover was 0.13 for fiscal 2025.

View full Royalty Pharma company overview

Royalty Pharma annual asset turnover history

Royalty Pharma annual asset turnover

Fiscal yearPeriod endedAsset turnoverChangeGrowth
20252025-12-310.13−0.01−3.93%
20242024-12-310.13−0.01−7.78%
20232023-12-310.140.01+8.84%
20222022-12-310.13−0.01−4.54%
20212021-12-310.14−0.01−8.42%
20202020-12-310.15

Royalty Pharma asset turnover trends

Over the last five fiscal years, Royalty Pharma's asset turnover decreased from 0.15 to 0.13, a change of −0.02. The latest reported quarter, Q2 2026, shows 0.13.

About the metric

What asset turnover means

Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.

Calculation and source

How asset turnover is calculated

TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Royalty Pharma source filings ↗

Community posts

It’s quiet here.

No posts about RPRX yet. Start the conversation.

Write the first post